-
$25,000
0.0% of portfolio
-
Q2 2025
New
-
$407,000
0.0% of portfolio
-
Q2 2025
Added 186.94%
$97.9M
$264,000
0.0% of portfolio
36,182
Q2 2025
Reduced 8.43%
$42.8B
$54,000
0.0% of portfolio
133
Q2 2025
Reduced 81.86%
$343M
$56,000
0.0% of portfolio
8,171
Q2 2025
Reduced 6.6%
-
$170,000
0.0% of portfolio
-
Q2 2025
Reduced 15.4%
$57.6B
$634,000
0.0% of portfolio
2,606
Q2 2025
Reduced 90.47%
$305B
$2.41 Million
0.0% of portfolio
16,830
Q2 2025
Reduced 66.68%
$4.19B
$1.2 Million
0.0% of portfolio
28,109
Q2 2025
New
China Sxt Pharmaceuticals In
-
$0
0.0% of portfolio
-
Q1 2025
New
$3.58B
$742,000
0.0% of portfolio
7,347
Q2 2025
New
$112M
$545,000
0.0% of portfolio
92,654
Q2 2025
Added 2.55%
-
$584,000
0.0% of portfolio
-
Q1 2025
Added 1,575.06%
$170M
$1.55 Million
0.0% of portfolio
112,680
Q2 2025
Added 14.91%
$321M
$783,000
0.0% of portfolio
33,814
Q1 2025
Added 15.06%
$2.74B
$473,000
0.0% of portfolio
17,217
Q2 2025
Reduced 57.86%
$506M
$1.32 Million
0.0% of portfolio
463,191
Q2 2025
Added 1,266.02%
$538M
$516,000
0.0% of portfolio
265,595
Q2 2025
New
$12.8B
$161,000
0.0% of portfolio
697
Q4 2024
Reduced 49.09%
$358M
$160,000
0.0% of portfolio
5,900
Q2 2025
New
-
$1.39 Million
0.0% of portfolio
46,070
Q2 2025
Added 64.64%
-
$246,000
0.0% of portfolio
-
Q1 2025
Reduced 75.11%
$20.4B
$107,000
0.0% of portfolio
1,551
Q3 2024
Reduced 94.88%
$543M
$747,000
0.0% of portfolio
32,709
Q2 2025
Reduced 10.5%
$4.46B
$265,000
0.0% of portfolio
6,887
Q2 2025
Reduced 57.59%
$5.59B
$75,000
0.0% of portfolio
2,248
Q2 2025
Reduced 87.88%
$40.5B
$975,000
0.0% of portfolio
10,522
Q2 2025
Reduced 56.64%
$85.9M
$48,000
0.0% of portfolio
5,909
Q4 2024
New
$160M
$200,000
0.0% of portfolio
82,037
Q2 2025
Reduced 79.24%
$27.3M
$46,000
0.0% of portfolio
10,809
Q2 2025
Reduced 47.96%
$37.9M
$216,000
0.0% of portfolio
701,940
Q2 2025
Reduced 30.33%
$98.7M
$37,000
0.0% of portfolio
51,640
Q2 2025
Reduced 73.78%
$47.1B
$100,000
0.0% of portfolio
289
Q2 2025
Reduced 98.97%
$301M
$58,000
0.0% of portfolio
3,533
Q1 2025
Reduced 79.52%
$3.31B
$69,000
0.0% of portfolio
1,146
Q2 2025
New
$423M
$533,000
0.0% of portfolio
34,975
Q2 2025
New
$27.3B
$359,000
0.0% of portfolio
671
Q2 2025
Added 297.04%
$395M
$475,000
0.0% of portfolio
140,001
Q2 2025
New
$4.67B
$1.79 Million
0.0% of portfolio
912,951
Q2 2025
Reduced 73.92%
$514M
$3,000
0.0% of portfolio
539
Q2 2025
Added 11.83%
-
$427,000
0.0% of portfolio
-
Q4 2023
New
$409M
$48,000
0.0% of portfolio
7,933
Q2 2025
Reduced 20.42%
$117B
$198,000
0.0% of portfolio
2,211
Q2 2025
Reduced 95.54%
$556M
$658,000
0.0% of portfolio
28,586
Q2 2025
Added 85.43%
$21.5B
$103,000
0.0% of portfolio
637
Q3 2024
Reduced 83.19%
$106B
$53,000
0.0% of portfolio
165
Q2 2025
Reduced 99.4%
$2.2B
$287,000
0.0% of portfolio
21,685
Q2 2025
New
Contineum Therapeutics Inc
-
$21,000
0.0% of portfolio
-
Q2 2025
New
-
$691,000
0.0% of portfolio
-
Q2 2025
Added 1,249.72%
Corbus Pharmaceuticals Hldgs
-
$1.05 Million
0.0% of portfolio
-
Q2 2025
Reduced 19.9%